Prestige Wealth Management Group LLC Astrazeneca PLC Transaction History
Prestige Wealth Management Group LLC
- $442 Million
- Q2 2024
A detailed history of Prestige Wealth Management Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 209 shares of AZN stock, worth $16,287. This represents 0.0% of its overall portfolio holdings.
Number of Shares
209
Previous 216
3.24%
Holding current value
$16,287
Previous $14,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,333Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.06 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.32 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.16 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.86 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.37 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...